West Pharmaceutical Services, Inc.WSTNYSE
LOADING
|||
EBITDA Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$743.80M
↑ 38% above average
Average (9y)
$538.18M
Historical baseline
Range
High:$879.70M
Low:$217.70M
CAGR
+14.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $743.80M | -11.9% |
| 2023 | $844.10M | +4.5% |
| 2022 | $808.10M | -8.1% |
| 2021 | $879.70M | +69.5% |
| 2020 | $518.90M | +28.7% |
| 2019 | $403.20M | +14.2% |
| 2018 | $353.20M | +8.3% |
| 2017 | $326.20M | +13.7% |
| 2016 | $286.90M | +31.8% |
| 2015 | $217.70M | - |